Commonwealth Equity Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.4M Sell
132,371
-15,276
-10% -$2.61M 0.03% 529
2025
Q4
$24.9M Buy
147,647
+7,963
+6% +$1.29M 0.03% 490
2025
Q3
$20.2M Sell
139,684
-40,935
-23% -$5.59M 0.03% 574
2025
Q2
$22.9M Sell
180,619
-13,897
-7% -$1.71M 0.03% 536
2025
Q1
$24.9M Buy
194,516
+20,915
+12% +$2.84M 0.04% 484
2024
Q4
$23M Sell
173,601
-6,818
-4% -$958K 0.03% 483
2024
Q3
$26.3M Sell
180,419
-9,325
-5% -$1.35M 0.04% 435
2024
Q2
$26M Sell
189,744
-8,965
-5% -$1.2M 0.04% 417
2024
Q1
$27.3M Buy
198,709
+10,033
+5% +$1.37M 0.05% 393
2023
Q4
$25.6M Sell
188,676
-17,416
-8% -$2.12M 0.05% 376
2023
Q3
$25.2M Sell
206,092
-12,096
-6% -$1.54M 0.05% 332
2023
Q2
$27.7M Sell
218,188
-11,527
-5% -$1.5M 0.06% 316
2023
Q1
$29.7K Sell
229,715
-45,807
-17% -$6M 0.06% 275
2022
Q4
$36.2M Buy
275,522
+40,640
+17% +$5.25M 0.09% 220
2022
Q3
$27.5M Buy
234,882
+44,738
+24% +$5.56M 0.07% 255
2022
Q2
$22.4M Sell
190,144
-6,405
-3% -$760K 0.06% 304
2022
Q1
$25.6M Sell
196,549
-10,348
-5% -$1.35M 0.06% 300
2021
Q4
$31.6M Buy
206,897
+18,397
+10% +$2.85M 0.07% 263
2021
Q3
$30.5M Buy
188,500
+2,379
+1% +$400K 0.08% 251
2021
Q2
$30.5M Buy
186,121
+151
+0.1% +$23.3K 0.08% 248
2021
Q1
$28M Sell
185,970
-10,583
-5% -$1.68M 0.08% 248
2020
Q4
$29.8M Sell
196,553
-42,688
-18% -$6.1M 0.09% 223
2020
Q3
$32.4M Buy
239,241
+36,072
+18% +$4.89M 0.11% 192
2020
Q2
$27.8M Buy
203,169
+60,887
+43% +$7.76M 0.1% 198
2020
Q1
$15.3M Sell
142,282
-2,702
-2% -$311K 0.07% 256
2019
Q4
$17.5M Sell
144,984
-10,168
-7% -$1.13M 0.07% 280
2019
Q3
$15.4M Sell
155,152
-24,386
-14% -$2.55M 0.07% 280
2019
Q2
$19.6M Sell
179,538
-25,476
-12% -$2.71M 0.09% 227
2019
Q1
$22.9M Buy
205,014
+1,936
+1% +$212K 0.11% 197
2018
Q4
$19.6M Buy
203,078
+7,565
+4% +$803K 0.1% 188
2018
Q3
$23.8M Buy
195,513
+616
+0.3% +$72.5K 0.11% 173
2018
Q2
$21.4M Sell
194,897
-10,435
-5% -$1.12M 0.11% 173
2018
Q1
$21.9M Sell
205,332
-22,950
-10% -$2.54M 0.12% 166
2017
Q4
$24.4M Buy
228,282
+16,719
+8% +$1.79M 0.13% 153
2017
Q3
$23.5M Buy
211,563
+2,649
+1% +$283K 0.14% 145
2017
Q2
$21.6M Sell
208,914
-1,758
-0.8% -$173K 0.14% 144
2017
Q1
$20.6M Buy
210,672
+14,994
+8% +$1.44M 0.14% 146
2016
Q4
$17.3M Sell
195,678
-6,114
-3% -$556K 0.13% 162
2016
Q3
$19.5M Buy
201,792
+19,179
+11% +$1.82M 0.15% 141
2016
Q2
$15.7M Sell
182,613
-4,974
-3% -$446K 0.13% 162
2016
Q1
$16.3M Sell
187,587
-46,203
-20% -$4.13M 0.15% 141
2015
Q4
$26.4M Buy
233,790
+279
+0.1% +$30.3K 0.25% 85
2015
Q3
$23.6M Buy
233,511
+21,225
+10% +$2.55M 0.25% 84
2015
Q2
$26.1M Buy
212,286
+5,496
+3% +$658K 0.26% 81
2015
Q1
$23.7M Buy
206,790
+17,274
+9% +$1.91M 0.25% 85
2014
Q4
$19.2M Buy
189,516
+10,824
+6% +$1.05M 0.21% 96
2014
Q3
$16.3M Buy
178,692
+11,568
+7% +$1.02M 0.2% 108
2014
Q2
$14.3M Sell
167,124
-41,631
-20% -$3.28M 0.17% 116
2014
Q1
$16.4M Buy
208,755
+3,003
+1% +$250K 0.23% 92
2013
Q4
$15.6M Buy
205,752
+59,670
+41% +$4.23M 0.23% 94
2013
Q3
$10.2M Buy
146,082
+64,695
+79% +$4.24M 0.17% 126
2013
Q2
$4.72M Buy
+81,387
New +$4.7M 0.08% 220

Other funds holding IBB